ENTITY
JD Health International

JD Health International (6618 HK)

433
Analysis
Consumer StaplesChina
JD Health International Inc. operates drug stores. The Company retails Chinese and Western medicines, nutrition products, health care products, and other products. JD Health International markets its products throughout China.
more
15 Dec 2020 09:40

Blue Moon Group IPO Trading - Too Expensive for Our Liking but Retail Traders Seem to Like It

Blue Moon Group Holdings (BMG HK) (BMG) raised around US$1.4bn in its Hong Kong listing. The company is backed by Hillhouse who first invested in...

Logo
510 Views
Share
13 Dec 2020 09:59

ECM Weekly (13 December 2020) - Vesync, Sino-Ocean, Jacobio, Netjoy, Sea, Xpeng, NIO, and More!

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
bullishPop Mart
10 Dec 2020 17:05

Pop Mart International IPO: Trading Debut

Pop Mart priced its IPO at HK$38.50 and opened 82% higher at HK$70.00 in the grey market. Our DCF sensitivity analysis shows that the IPO price...

Logo
647 Views
Share
bullishPop Mart
10 Dec 2020 09:28

Pop Mart IPO Trading - Set for a Pop but We Won't Be Chasing

POP MART raised around US$775m in its Hong Kong IPO. Pop Mart is the largest and fastest growing pop toy company in China, in terms of 2019 revenue...

Logo
520 Views
Share
09 Dec 2020 08:48

JD Health (京东健康) Quick Note - Index Inclusions, Weights, and Valuation Update

JD Health (6618 HK) closed +56% higher on its trading debut. Post market close, MSCI and FTSE announced JDH's early inclusion and fast entry,...

Share
x